Taiwan FDA registration a76305e1a0186c7dcaa7e0aa0ad517df

Pson hepatitis B virus real-time quantitative reagent

TW: 普生B型肝炎病毒即時定量試劑

Taiwan·Risk Class 3·GENERAL BIOLOGICALS CORP.·Registered Aug 31, 2009 – Aug 31, 2029Active

Registration details

Analysis ID: a76305e1a0186c7dcaa7e0aa0ad517df
Customs Code: DHY00500300405

Company information

Manufacturer: GENERAL BIOLOGICALS CORP.
Manufacturer Country: Taiwan, Province of China
Authorized Representative: GENERAL BIOLOGICALS CORP.

Product details

Intended Use: Quantitative analysis of hepatitis B virus DNA in human serum
Product Type (Level 1): B Hematology, pathology, and genetics
Product Type (Level 2): B.4020 Analysis of specific tests
Import Information: Domestic

Dates and status

Registration Date: Aug 31, 2009
Expiry Date: Aug 31, 2029

About this record

Access comprehensive regulatory information for Pson hepatitis B virus real-time quantitative reagent in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 3 medical device is registered under number a76305e1a0186c7dcaa7e0aa0ad517df and manufactured by GENERAL BIOLOGICALS CORP.. The authorized representative in Taiwan is GENERAL BIOLOGICALS CORP..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.